Immunoglobulin Light-Chain Isotype Switch (IS) during Lenalidomide Therapy in Multiple Myeloma and its Association with Increased M Protein Production and Miliary TB
Multiple Myeloma (MM) is a malignant neoplasm arising from a single plasma cell clone. It mainly affects older people. It forms localised osteolytic lesions. It secretes a single monoclonal immunoglobulin of constant isotype with light-chain restriction (paraprotein). MM cells may express, an adhesi...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2019-04-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/12763/40096_CE[Ra1]_F(AC)_PF1(AB_KM_SL)_PN(SL).pdf |
id |
doaj-07ce3fc33941496d8a02c65b086b4aae |
---|---|
record_format |
Article |
spelling |
doaj-07ce3fc33941496d8a02c65b086b4aae2020-11-25T03:08:07ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2019-04-01134ED04ED0510.7860/JCDR/2019/40096.12763Immunoglobulin Light-Chain Isotype Switch (IS) during Lenalidomide Therapy in Multiple Myeloma and its Association with Increased M Protein Production and Miliary TBAshok Kumar Kapoor0Supriya Mehrotra1Rajesh Kumar Srivastava2Pathologist, Department of Pathology, RML Mehrotra Pathology Pvt. Ltd, Nirala Nagar, Lucknow, Uttar Pradesh, India.Pathologist, Department of Pathology, RML Mehrotra Pathology Pvt. Ltd, Nirala Nagar, Lucknow, Uttar Pradesh, India.Senior Technologist, Department of Pathology, RML Mehrotra Pathology Pvt. Ltd, Nirala Nagar, Lucknow, Uttar Pradesh, India.Multiple Myeloma (MM) is a malignant neoplasm arising from a single plasma cell clone. It mainly affects older people. It forms localised osteolytic lesions. It secretes a single monoclonal immunoglobulin of constant isotype with light-chain restriction (paraprotein). MM cells may express, an adhesion molecule. This molecule is not present on normal plasma cell. In addition, immunoglobulin light-chain may be detected in urine (Bence jones proteins). Rarely, one of the isotypes may switch to another type during high-dose chemotherapy. In addition, Isotype Switch (IS) may occur spontaneously without any treatment. The present case relates about an 87-year-old man who complained of pain in dorsal thoracic region. X-ray examination showed fractures of thoracic vertebra eighth to tenth. Sternal puncture was done. Bone marrow examination showed large number of plasmacytoid cells. Moreover, serum protein electrophoresis revealed moderately raised M band proteins in gamma globulin region (M band protein concentration was 2.03 gm/dL). The patient was diagnosed as a case of MM. Initially, he was treated with Thalidomide 100 mg daily for one month. Later, he was treated with Lenalidomide 10 mg daily for 30 days followed by a drug-free period of 15 days. After eight cycles of Lenalidomide therapy light-chain IS was detected. Initially, tumour produced lambda (λ) light-chain for one year as seen in first, second and third serum specimens. Later, light-chain switch was detected in fourth serum specimen from lambda (λ) to kappa (k) light-chain. IS was accompanied with high level of M band proteins (5.4 gm/dL). In addition, the patient developed Miliary Tuberculosis. Subsequently, the patient was treated with Phaglomide (Pomalidomide) instead of Lenalidomide.https://jcdr.net/articles/PDF/12763/40096_CE[Ra1]_F(AC)_PF1(AB_KM_SL)_PN(SL).pdfcd56kappa light-chainplasmacytoma lambda light-chain |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ashok Kumar Kapoor Supriya Mehrotra Rajesh Kumar Srivastava |
spellingShingle |
Ashok Kumar Kapoor Supriya Mehrotra Rajesh Kumar Srivastava Immunoglobulin Light-Chain Isotype Switch (IS) during Lenalidomide Therapy in Multiple Myeloma and its Association with Increased M Protein Production and Miliary TB Journal of Clinical and Diagnostic Research cd56 kappa light-chain plasmacytoma lambda light-chain |
author_facet |
Ashok Kumar Kapoor Supriya Mehrotra Rajesh Kumar Srivastava |
author_sort |
Ashok Kumar Kapoor |
title |
Immunoglobulin Light-Chain Isotype Switch (IS) during Lenalidomide Therapy in Multiple Myeloma and its Association with Increased M Protein Production and Miliary TB |
title_short |
Immunoglobulin Light-Chain Isotype Switch (IS) during Lenalidomide Therapy in Multiple Myeloma and its Association with Increased M Protein Production and Miliary TB |
title_full |
Immunoglobulin Light-Chain Isotype Switch (IS) during Lenalidomide Therapy in Multiple Myeloma and its Association with Increased M Protein Production and Miliary TB |
title_fullStr |
Immunoglobulin Light-Chain Isotype Switch (IS) during Lenalidomide Therapy in Multiple Myeloma and its Association with Increased M Protein Production and Miliary TB |
title_full_unstemmed |
Immunoglobulin Light-Chain Isotype Switch (IS) during Lenalidomide Therapy in Multiple Myeloma and its Association with Increased M Protein Production and Miliary TB |
title_sort |
immunoglobulin light-chain isotype switch (is) during lenalidomide therapy in multiple myeloma and its association with increased m protein production and miliary tb |
publisher |
JCDR Research and Publications Private Limited |
series |
Journal of Clinical and Diagnostic Research |
issn |
2249-782X 0973-709X |
publishDate |
2019-04-01 |
description |
Multiple Myeloma (MM) is a malignant neoplasm arising from a single plasma cell clone. It mainly affects older people. It forms localised osteolytic lesions. It secretes a single monoclonal immunoglobulin of constant isotype with light-chain restriction (paraprotein). MM cells may express, an adhesion molecule. This molecule is not present on normal plasma cell. In addition, immunoglobulin light-chain may be detected in urine (Bence jones proteins). Rarely, one of the isotypes may switch to another type during high-dose chemotherapy. In addition, Isotype Switch (IS) may occur spontaneously without any treatment. The present case relates about an 87-year-old man who complained of pain in dorsal thoracic region. X-ray examination showed fractures of thoracic vertebra eighth to tenth. Sternal puncture was done. Bone marrow examination showed large number of plasmacytoid cells. Moreover, serum protein electrophoresis revealed moderately raised M band proteins in gamma globulin region (M band protein concentration was 2.03 gm/dL). The patient was diagnosed as a case of MM. Initially, he was treated with Thalidomide 100 mg daily for one month. Later, he was treated with Lenalidomide 10 mg daily for 30 days followed by a drug-free period of 15 days. After eight cycles of Lenalidomide therapy light-chain IS was detected. Initially, tumour produced lambda (λ) light-chain for one year as seen in first, second and third serum specimens. Later, light-chain switch was detected in fourth serum specimen from lambda (λ) to kappa (k) light-chain. IS was accompanied with high level of M band proteins (5.4 gm/dL). In addition, the patient developed Miliary Tuberculosis. Subsequently, the patient was treated with Phaglomide (Pomalidomide) instead of Lenalidomide. |
topic |
cd56 kappa light-chain plasmacytoma lambda light-chain |
url |
https://jcdr.net/articles/PDF/12763/40096_CE[Ra1]_F(AC)_PF1(AB_KM_SL)_PN(SL).pdf |
work_keys_str_mv |
AT ashokkumarkapoor immunoglobulinlightchainisotypeswitchisduringlenalidomidetherapyinmultiplemyelomaanditsassociationwithincreasedmproteinproductionandmiliarytb AT supriyamehrotra immunoglobulinlightchainisotypeswitchisduringlenalidomidetherapyinmultiplemyelomaanditsassociationwithincreasedmproteinproductionandmiliarytb AT rajeshkumarsrivastava immunoglobulinlightchainisotypeswitchisduringlenalidomidetherapyinmultiplemyelomaanditsassociationwithincreasedmproteinproductionandmiliarytb |
_version_ |
1724667408194469888 |